• Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
  • Facebook
  • Twitter
The Wall Street Analyzer

  • Featured Interviews
  • CEO Interviews
  • News Feed
  • Spotlight
  • Sectors
    • Biotech
    • Cannabis
    • Consumer
    • Energy
    • Healthcare
    • Market News
    • Technology
Latest News
  • [ February 2, 2023 ] XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease News Feed
  • [ January 31, 2023 ] Zerify Starts The Year Off Strong News Feed
  • [ January 26, 2023 ] SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE News Feed
  • [ January 24, 2023 ] Zomedica to Participate in the Lytham Partners Investor Select Conference News Feed
  • [ January 23, 2023 ] XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial News Feed
  • [ January 18, 2023 ] Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies News Feed
  • [ January 17, 2023 ] SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS News Feed
Home2022

Year: 2022

Investor Education

The cost of delaying Investment Decisions | Best of Investor Education

December 13, 2022 The Wall Street Analyzer 0
Investor Education

Investor Education Series | How to Invest in Private Placements: FOR BEGINNERS

December 13, 2022 The Wall Street Analyzer 0
Investor Education

What are liquid ETFs? || Best Of Investor Education

December 13, 2022 The Wall Street Analyzer 0
Investor Education

Dave Ramsey’s Speech Will Change Your Financial Future (MUST Watch!)

December 13, 2022 The Wall Street Analyzer 0
News Feed

Nashville Record Label Signs-up to Protect Intellectual Property Using Zerify Meet

December 13, 2022 The Wall Street Analyzer 0

EDISON, N.J., Dec. 13, 2022 (GLOBE NEWSWIRE) — Zerify Inc. (OTCQB: ZRFY), the 21-year-old cyber security company focused on secure video conferencing solutions, is pleased to announce that the Nashville record label “The Service” is using […]

CEO Interviews

Predictive Oncology (NASDAQ: POAI)

December 13, 2022 The Wall Street Analyzer 0

ABOUT: Predictive Oncology (NASDAQ: POAI) is a knowledge-driven company focused on applying artificial intelligence (AI) to develop optimal cancer therapies, which can ultimately lead to more effective treatments and improved patient outcomes. Through AI, Predictive Oncology uses […]

CEO Interviews

American Rare Earths Ltd (OTCQB: ARNNF) (ASX:ARR)

December 12, 2022 The Wall Street Analyzer 0

Interview with Christopher Gibbs, CEO and Marty Weems, President of North American Division […]

News Feed

CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD

December 12, 2022 The Wall Street Analyzer 0

Drug Candidate, CQ-001 (cannabidiol “CBD” + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.
[…]

No Picture
CEO Interviews

RepliCel Life Sciences Inc. (TSXV:RP)(OTC PINK: REPCF)

December 12, 2022 The Wall Street Analyzer 0

THIS INTERVIEW HAS EXPIRED

News Feed

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

December 9, 2022 The Wall Street Analyzer 0

Independent Study Shows Moderate Dose Strength of XORLO™ Attenuates Kidney Expansion […]

Posts navigation

« 1 2 3 … 16 »

Featured Companies

CEO Interviews

Zomedica Corp. (NYSE American: ZOM)

November 29, 2022 0

Interview update with Larry Heaton, CEO and President […]

CEO Interviews

Acutus Medical (NASDAQ: AFIB)

November 19, 2022 0

Interview with David Roman, CEO […]

Featured Interviews

Zerify (OTCQB: ZRFY)

November 18, 2022 0

Interview with Mark Kay, CEO and Chairman […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (NASDAQ: XRTF)

October 25, 2022 0

Interview update with Dr. Allen Davidoff, CEO
[…]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX) CEO Interview Update

October 24, 2022 0

Interview with Rick Van Kirk, CEO […]

News Wire

  • XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
    February 2, 2023 0
  • Zerify Starts The Year Off Strong
    January 31, 2023 0
  • SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE
    January 26, 2023 0
  • Zomedica to Participate in the Lytham Partners Investor Select Conference
    January 24, 2023 0
  • XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
    January 23, 2023 0
  • Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
    January 18, 2023 0
  • SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS
    January 17, 2023 0




Follow on Facebook

About Us

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Quick links
  • Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
Stay connected
  • Facebook
  • Twitter
Recent Case Study
Biotech

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

August 12, 2019 Comments Off on Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

About Co-Diagnostics, Inc: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection […]

Testimonials
Testimonials

Client Testimonials:

June 1, 2020 Comments Off on Client Testimonials:

“What we like most about the wallstreetanalyzer.com was their service consistently brought Marifil Mines Ltd new viewers to our company.  The interviews are high quality, to the point, friendly and enlightening.  We have been using his […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com